š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study is designed to compare the effectiveness of intradermal injectio...
Status
Unknown
Location
Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Start Date
2015-05
Trial ID
NCT02982148
Treatments Being Tested
This is a post-market, monocentric, interventional, single-arm, confirmativ...
Status
Completed
Location
Clinica di Chirurgia plastica e ricostruttiva/Ospedale Policlinico San Martino
Start Date
2024-12-18
Trial ID
NCT06821867
Treatments Being Tested
The aim of this trial is to evaluate the safety and immunogenicity of the 2...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02258334
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Allergy-Centre-CharitƩ
Start Date
2008-01
Trial ID
NCT00685711
Treatments Being Tested
This trial aims to test the safety of 2 doses of a T-cell priming specific ...
Status
Completed
Location
Center for Primary Care and Public Health, (Unisante)
Start Date
2021-08-02
Trial ID
NCT04935801
Treatments Being Tested
INVAC-1 is intended to be used for the treatment of adult patients with adv...
Status
Completed
Location
HĆ“pital Saint Louis
Start Date
2014-11
Trial ID
NCT02301754
Treatments Being Tested
The study is a two centre, open-label, uncontrolled single group phase 1A s...
Status
Completed
Location
Cardiff and Vale University Health Board
Start Date
2016-09-29
Trial ID
NCT02837094
Treatments Being Tested
This study will examine the efficacy of Botulinum Toxin Type A ("Botox") in...
Status
Terminated
Location
WRHA Health Sciences Centre Rehabilitation Hospital
Start Date
2013-10
Trial ID
NCT01911377
Treatments Being Tested
This is a Phase II study of Vigilā¢ autologous tumor cell vaccine integrated...
Status
Completed
Location
Mary Crowley Cancer Research Centers
Start Date
2013-06
Trial ID
NCT01867086
Treatments Being Tested
Human Immunodeficiency Virus (HIV) is the strongest individual risk factor ...
Status
Unknown
Location
Ian Charleson Centre, Royal Free Hospital
Start Date
2013-06
Trial ID
NCT02712671